Medication info
Hyutecs Risedronate Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)

Hyutecs Risedronate Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›35mg / 1 tablet
Manufacturer / importer
Hyutecs Pharmaceutical Co., Ltd.
Appearance
Yellow oblong film-coated tablet
Packaging
4 tablets/PTP [4 tablets/PTP x 1]
Approval status
Active

MFDS item code 200713890 · Notified 2007.12.31 · Insurance code 649101530

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults : Administer sodium risedronate 35 mg orally once weekly. 2. Older adults : No dose adjustment is necessary in older adults (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dose adjustment is necessary in patients with a creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. ○ Since food interferes with the absorption of this medicine, for adequate absorption take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
3. Children : The safety and efficacy of this medicine in children under 18 years of age have not been established.

Ingredients

Manufacturer
Hyutecs Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men. Osteoporosis is a condition that causes bones to weaken and become prone to fractures, and this drug helps improve that condition. Therefore, this medication is effective in enhancing bone health and reducing the risk of fractures.

How to take

Adult dose

1. Adults : Administer sodium risedronate 35 mg orally once weekly. 2. Older adults : No dose adjustment is necessary in older adults (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dose adjustment is necessary in patients with a creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. ○ Since food interferes with the absorption of this medicine, for adequate absorption take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

3. Children : The safety and efficacy of this medicine in children under 18 years of age have not been established.

Precautions

This medication may irritate the mucosa of the stomach and esophagus, so special caution is required for individuals with gastritis or esophageal conditions. When taking this medication, it should be taken sitting or standing, with a sufficient amount of water, and one should not lie down for at least 30 minutes after taking it. If symptoms such as esophagitis, dysphagia, heartburn occur, stop taking the medication immediately and consult a doctor. This medication is contraindicated in patients with certain esophageal diseases or severely impaired kidney function, as well as in pregnant or breastfeeding women. If there is a deficiency of calcium and vitamin D, it is important to supplement these before taking this medication, and taking it with calcium or divalent cation-containing medications may inhibit absorption. Rarely, long-term use may result in side effects such as osteonecrosis of the jaw, atypical fractures, severe bone, joint, and muscle pain; therefore, inform your doctor of any unusual symptoms. While taking this medication, allergic reactions or skin rashes, eye inflammation may rarely occur, so caution is needed. The safety and efficacy of this medication have not been established in children, and special caution is not necessary for the elderly. In cases of overdose, symptoms of hypocalcemia may occur, and immediate medical attention should be sought.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • infection
  • back pain
  • accidental injury
  • pain
Show 58 more
  • abdominal pain
  • flu symptoms
  • headache
  • fatigue
  • throat pain
  • chest pain
  • allergic reaction
  • hypertension
  • constipation
  • diarrhea
  • dyspepsia
  • nausea
  • peripheral edema
  • arthralgia
  • arthritis
  • fracture
  • joint abnormalities
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased cough
  • rash
  • cataract
  • urinary tract infection
  • vomiting
  • uveitis
  • scleritis
  • iritis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • Lyell's syndrome
  • angioedema
  • blister
  • skin reaction
  • external auditory canal osteonecrosis
  • jaw necrosis
  • liver function impairment
  • jaundice
  • loss of appetite
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • eye pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture entry. The storage temperature should be maintained between 1 degree and 30 degrees at room temperature.

Appearance and packaging

Appearance

Yellow oblong film-coated tablet

Package unit

4 tablets/PTP [4 tablets/PTP x 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.